Wound Biologics Market Size, Share & Trend Report

Wound Biologics Market Size, Share & Trend Analysis Report By Product (Biological Skin Substitutes, Topical Agents), By Wound Type (Chronic, Acute), and Regional Segment Forecasts, 2019 - 2026

Report ID: GVR-3-68038-966-1
Number of Pages: 108
Format: Electronic (PDF)

Historical Range: 2015 - 2017
Industry: Healthcare

Market Segmentation

Wound Biologics Market, Product Outlook (Revenue, USD Million; 2015 - 2026)
- Biological Skin Substitutes
  - Allograft
  - Xenograft
  - Biosynthetic Products
- Topical Agents
- Collagen Dressing
Wound Biologics Market, Wound Type Outlook (Revenue, USD Million; 2015 - 2026)
- Chronic Wounds
- Acute Wounds
Wound Biologics Market, End-Use Outlook (Revenue, USD Million; 2015 - 2026)
- Hospitals
- Clinics
- Others
Wound Biologics Market, Regional Outlook (Revenue, USD Million; 2015 - 2026)
- North America
  - North America wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
    - Biological skin substitutes
      - Allograft
      - Xenograft
      - Biosynthetic products
    - Topical agents
    - Collagen dressing
  - North America wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
    - Chronic wounds
    - Acute wounds
  - North America wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
    - Hospitals
    - Clinics
    - Others
  - The U.S.
    - U.S. wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - U.S. wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - U.S. wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
  - Canada
    - Canada wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - Canada wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - Canada wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
- Europe
  - Europe wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
    - Biological skin substitutes
      - Allograft
      - Xenograft
      - Biosynthetic products
    - Topical agents
    - Collagen dressing
  - Europe wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
    - Chronic wounds
    - Acute wounds
  - Europe wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
    - Hospitals
    - Clinics
    - Others
  - UK
    - UK wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - UK wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - UK wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
  - Germany
    - Germany wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - Germany wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - Germany wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
- Asia Pacific
  - Asia Pacific wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
    - Biological skin substitutes
      - Allograft
      - Xenograft
      - Biosynthetic products
    - Topical agents
    - Collagen dressing
  - Asia Pacific wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
    - Chronic wounds
    - Acute wounds
  - Asia Pacific wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
    - Hospitals
    - Clinics
    - Others
  - China
    - China wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - China wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - China wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
  - Japan
    - Japan wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - Japan wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - Japan wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
- Latin America
  - Latin America wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
    - Biological skin substitutes
      - Allograft
      - Xenograft
      - Biosynthetic products
    - Topical agents
    - Collagen dressing
  - Latin America wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
    - Chronic wounds
    - Acute wounds
  - Latin America wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
    - Hospitals
    - Clinics
    - Others
  - Brazil
    - Brazil wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - Brazil wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - Brazil wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
  - Mexico
    - Mexico wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - Mexico wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - Mexico wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
- MEA
  - MEA wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
    - Biological skin substitutes
      - Allograft
      - Xenograft
      - Biosynthetic products
    - Topical agents
    - Collagen dressing
  - MEA wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
    - Chronic wounds
    - Acute wounds
  - MEA wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
    - Hospitals
    - Clinics
    - Others
  - South Africa
    - South Africa wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - South Africa wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - South Africa wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others
  - Saudi Arabia
    - Saudi Arabia wound biologics market, by product (Revenue, USD Million; 2015 - 2026)
      - Biological skin substitutes
        
        Allograft
        
        Xenograft
        
        Biosynthetic products
      - Topical agents
      - Collagen dressing
    - Saudi Arabia wound biologics market, by wound type (Revenue, USD Million; 2015 - 2026)
      - Chronic wounds
      - Acute wounds
    - Saudi Arabia wound biologics market, by end-use (Revenue, USD Million; 2015 - 2026)
      - Hospitals
      - Clinics
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2015 to 2026
Market estimates and forecast for product segments up to 2026
Regional market size and forecast for product segments up to 2026
Market estimates and forecast for application segments up to 2026
Regional market size and forecast for application segments up to 2026
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.